Real-world effectiveness and safety of Ocrelizumab in a gulf multiple sclerosis cohort: extension of the Q-OCRE study to 451 patients.

Zammar K, Abualrob MA, Yasin R, Althani A, Alemadi A, Hassanein D, Alshehab S, Baniamer Y, Eltazi I, Abdelmoneim M S, et al.

Mult Scler Relat Disord. 2026 Oct 07; 115:107971. PMID: 42858537. Abstract